01 1Active Pharma Inc.
02 1Assia Chemical Industries Ltd.
03 1Daito Co., Ltd.
04 1JUBILANT PHARMOVA LIMITED
05 1Osaka Synthetic Organic Chemistry Laboratory Co., Ltd.
06 1Shijiazhuang Lonzeal Pharmaceuticals Co. , Ltd.
07 1Sumitomo Chemical Co., Ltd.
08 1Zydus Lifesciences Limited
01 1Japanese Pharmacopoeia Paroxetine Hydrochloride Hydrate
02 1Only the Japanese Pharmacopoeia paroxetine hydrochloride hydrate production
03 1Paroxetine Hydrochloride Hydrate
04 4Paroxetine hydrochloride hydrate
05 1Paroxetine hydrochloride hydrate "Teva"
01 1China
02 2India
03 1Israel
04 4Japan
Paroxetine hydrochloride hydrate "Teva"
Registration Number : 223MF10002
Registrant's Address : Neot-Hovav Eco-Industrial Park, Emek Sara P. O. Box 2049 Be'er Sheva 8412316, Israel
Initial Date of Registration : 2011-01-07
Latest Date of Registration : 2011-11-17
Paroxetine hydrochloride hydrate
Registration Number : 222MF10257
Registrant's Address : 326 Yokamachi, Toyama City, Toyama Prefecture
Initial Date of Registration : 2010-11-18
Latest Date of Registration : 2011-11-07
Paroxetine Hydrochloride Hydrate
Registration Number : 231MF10081
Registrant's Address : 1A, Sector 16A, Noida 201 301, Uttar Pradesh, India
Initial Date of Registration : 2019-04-03
Latest Date of Registration : 2019-04-03
Japanese Pharmacopoeia Paroxetine Hydrochloride Hydrate For manufacturing only
Registration Number : 227MF10216
Registrant's Address : 1-1-2 Nishinomiyahama, Nishinomiya City, Hyogo Prefecture
Initial Date of Registration : 2015-08-31
Latest Date of Registration : 2015-08-31
Paroxetine hydrochloride hydrate
Registration Number : 222MF10283
Registrant's Address : 2-36-1 Kanda Jinbocho, Chiyoda-ku, Tokyo
Initial Date of Registration : 2010-12-27
Latest Date of Registration : 2012-10-01
Paroxetine hydrochloride hydrate
Registration Number : 304MF10042
Registrant's Address : Industrial Zone Shenze (No. 16, West Ring Road), Shijiazhuang, Hebei Province 052560 ...
Initial Date of Registration : 2022-02-24
Latest Date of Registration : 2022-02-24
Paroxetine hydrochloride hydrate
Registration Number : 222MF10199
Registrant's Address : 2-27-1 Shinkawa, Chuo-ku, Tokyo
Initial Date of Registration : 2010-07-14
Latest Date of Registration : 2010-07-14
Paroxetine Hydrochloride Hydrate
Registration Number : 222MF10207
Registrant's Address : Zydus Corporate Park, 3rd Floor, B Wing, Scheme No. 63, Survey No. 536, Plot No. 103,...
Initial Date of Registration : 2010-07-26
Latest Date of Registration : 2017-09-25
A Paroxetine Hydrochloride Hemihydrate manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Paroxetine Hydrochloride Hemihydrate, including repackagers and relabelers. The FDA regulates Paroxetine Hydrochloride Hemihydrate manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Paroxetine Hydrochloride Hemihydrate API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Paroxetine Hydrochloride Hemihydrate manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Paroxetine Hydrochloride Hemihydrate supplier is an individual or a company that provides Paroxetine Hydrochloride Hemihydrate active pharmaceutical ingredient (API) or Paroxetine Hydrochloride Hemihydrate finished formulations upon request. The Paroxetine Hydrochloride Hemihydrate suppliers may include Paroxetine Hydrochloride Hemihydrate API manufacturers, exporters, distributors and traders.
click here to find a list of Paroxetine Hydrochloride Hemihydrate suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.
The Paroxetine Hydrochloride Hemihydrate Drug Master File in Japan (Paroxetine Hydrochloride Hemihydrate JDMF) empowers Paroxetine Hydrochloride Hemihydrate API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).
PMDA reviews the Paroxetine Hydrochloride Hemihydrate JDMF during the approval evaluation for pharmaceutical products. At the time of Paroxetine Hydrochloride Hemihydrate JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.
click here to find a list of Paroxetine Hydrochloride Hemihydrate suppliers with JDMF on PharmaCompass.
We have 8 companies offering Paroxetine Hydrochloride Hemihydrate
Get in contact with the supplier of your choice:
LOOKING FOR A SUPPLIER?